SoftBank to lead nearly $1.2 billion investment in diagnostics firm Invitae By Reuters
(Reuters) - Invitae Corp said on Monday a group of investors including SoftBank Group Corp will invest $1.15 billion in the U.S. genetic diagnostics company. It said the investment, to be used for its growth initiatives, will be in convertible senior notes, which will bear 1.5% interest per year. The company said the notes will have an initial conversion price of $43.18...
Continue reading